The authors of a new white paper believe that almost 75% of pharmaceutical patent settlements at the Patent Trial and Appeal Board meet the criterion for inferring a strong likelihood of reverse payment settlement. The paper also suggests a rule to deter attempts to exploit the Board as a holdup device as well as discussing reverse patent trolls
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
Jorg Thomaier, who has been head of IP at the German pharma company since 2010, will leave later this year and hand the reins to the company’s head of patents
Celia Cheah at Wong & Partners in Malaysia says she is aiming to tap into the Baker McKenzie member firm’s international network and expand its IP portfolio
Abigail Struthers discusses why law firms are like a mix of small businesses and explains why hopeful patent lawyers should not assume that a science degree is essential
We review the latest batch of IP STARS rankings, analyse a major law firm collaboration following the opening of India’s legal market, and look at why Canadian brands are promoting ‘Canadianness’